Hyperfine booth

May 9, 2022
Latest in Clinical News
Dedicated breast F-18 FDG PET/MRI exam pre- (A, D, G), mid- (B, E, H), and post-NAC (C, F, I) of a 41-year-old patient diagnosed with a triple negative (TN), grade 2, invasive carcinoma. The SUVmax values of the primary tumor were 14.68 pre-NAC, 1.69 mid-NAC, and 1.87 post-NAC, while SER values were 1.19, 0.52, and 0.63, respectively. Figure courtesy of Melissa Lenaerts, PhD, Dr. Thiemo van Nijnatten, PhD, et al and presented at EUSOBI 2025.
PET/MRI begins to deliver in breast cancer
October 23, 2025
Join Us!
Sponsored
Join Us!
October 22, 2025
2025 10 20 Eanm Early Perfusion Imaging Fig1 Thumbnail
Amyloid PET can track patterns of neurodegeneration
October 22, 2025
Prostate 3 D 400
Pluvicto reduces progression of advanced prostate cancer
October 21, 2025
Related Stories
2022 05 08 18 10 6353 Pinker Katja 400
Conference
Video from ISMRM 2022: Katja Pinker-Domenig on breast MRI
2022 05 09 21 28 6735 2022 05 09 Ismrm Simcock Mri Pediatric 400
Conference
Radiologists can help achieve better pediatric care with MRI
2020 06 23 21 25 6650 Mri Abstract 400
Conference
Bruker launches 7T, 9.4T research MRI scanners at ISMRM
Join Us!
Sponsor Content
Join Us!
More in Clinical News
PET/MRI begins to deliver in breast cancer
By Philip Ward
The clinical role of PET/MRI is evolving rapidly in breast cancer, according to two studies presented at the European Society of Breast Imaging annual meeting.
October 23, 2025
Dedicated breast F-18 FDG PET/MRI exam pre- (A, D, G), mid- (B, E, H), and post-NAC (C, F, I) of a 41-year-old patient diagnosed with a triple negative (TN), grade 2, invasive carcinoma. The SUVmax values of the primary tumor were 14.68 pre-NAC, 1.69 mid-NAC, and 1.87 post-NAC, while SER values were 1.19, 0.52, and 0.63, respectively. Figure courtesy of Melissa Lenaerts, PhD, Dr. Thiemo van Nijnatten, PhD, et al and presented at EUSOBI 2025.
EUSOBI: Positron emission mammography demonstrates worth
By Edna Astbury-Ward, PhD
Positron emission mammography is proving useful in the presurgical assessment of invasive lobular carcinoma, researchers reported at the European Society of Breast Imaging (EUSOBI) annual meeting.
October 22, 2025
A 399 Fig 2 Pem Vs Cesm E Poster Eusobi 2025 Deabes Thumbnail
Amyloid PET can track patterns of neurodegeneration
By Maryam Payne
Early perfusion amyloid-PET shows potential for diagnosing and monitoring neurodegenerative disease and has possible advantages over FDG-PET scanning.
October 22, 2025
2025 10 20 Eanm Early Perfusion Imaging Fig1 Thumbnail
Pluvicto reduces progression of advanced prostate cancer
By AuntMinnieEurope.com staff writers
New study findings were presented on 19 October at the European Society for Medical Oncology 2025 annual meeting in Berlin.
October 21, 2025
Prostate 3 D 400
The epidemic of decision paralysis
By Dr. Paul McCoubrie
Decision-making is central to successful clinical practice, but no one seems to make decisions these days, writes Dr. Paul McCoubrie in the second part of his series about interactions between surgeons and radiologists.
October 21, 2025
Paul Mc Coubrie April 24
Global survey pinpoints key trends in spectral CT
By Liz Carey
The use of spectral CT is rising, but its clinical integration and quality assurance/quality control practices are inconsistent, the International Atomic Energy Agency has found.
October 20, 2025
Ct Scan Tech Adobe Stock By Peakstock g3ma9suare
Abnormal CT-FFR results translate to up to 7 years' cardiac risk
By Kate Madden Yee
The prognostic value of CT fractional flow reserve (CT-FFR) has been unclear, but the findings of a recent study from Denmark offer further insight.
October 20, 2025
Heart Damage
Transgender breast care emerges as priority for radiology
By Frances Rylands-Monk
Radiology needs to stop thinking of breast cancer as a disease that only concerns women and do much more to include transgender patients in breast care, says Dr. Anna D'Angelo from Rome.
October 20, 2025
Anna Portrait
PI-RADS v2.1 is 'highly sensitive' for prostate cancer detection on MRI
By Kate Madden Yee
PI-RADS v2.1 shows high sensitivity for categorizing clinically significant prostate cancer on MRI at both the patient and lesion levels, German researchers have found.
October 16, 2025
Benign Prostatic Hyperplasia
Breast CT gains clinical momentum in Europe
By Philip Ward
Dedicated contrast-enhanced breast CT is advancing as a clinical tool, but variations persist in acquisition protocols, particularly the timing of contrast administration. Dutch researchers have tried to resolve this issue.
October 16, 2025
Woman Lying On Ct Scanner Adobe Lasgkhidzetim
Vara granted CE mark for AI breast imaging software
By AuntMinnieEurope.com staff writers
Vara has received the CE mark for its AI breast imaging product for use as an independent second reader for screening and in diagnostic use as a decision support system.
October 15, 2025
Computer Ai Hud Display 400
Belgian study shows AI's promise in coronary ischemia
By Maryam Payne
A deep-learning model for assessing vessel-specific coronary ischemia performed well compared to invasive fractional flow reserve in a multicenter study published by European Radiology on 11 October.
October 15, 2025
2025 10 11 Er Peters Fig3 Thumbnail
Page 1 of 1296
Next Page